SC 13G/A

AMENDMENT NO. 4 TO THE SCHEDULE 13G

Company: Syndax Pharmaceuticals Inc
Filed: February 14, 2020
Accession Number: 0000921895-20-000574

View Document ↗ View on SEC.gov ↗